Status:
RECRUITING
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
Lead Sponsor:
Peking University Third Hospital
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oral lichen planus (OLP) is a common chronic inflammatory disease of the oral mucosa and is considered a precancerous condition. It is characterized by white reticular changes in the oral mucosa, whic...
Detailed Description
Paeoniflorin, a compound extracted from the traditional Chinese medicine, has anti-inflammatory and immunomodulatory effects. Photodynamic therapy is a novel local treatment approach, where photosensi...
Eligibility Criteria
Inclusion
- patients with oral lichen planus
- male or female patients older than 18 years of age
- patients willing to participate with signed informed consent.
Exclusion
- pregnant or lactating
- had serious systemic diseases of the heart, lung, liver, and kidney, or had tumors
- were unwilling to participate in the experiment.
Key Trial Info
Start Date :
July 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2028
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT05973097
Start Date
July 30 2023
End Date
December 30 2028
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China